EIKN · Eikon Therapeutics, Inc.
AI read · Good for EIKN
The AI's read
This gives Eikon a chance to test its prostate cancer drug in people. The drug is designed to target receptor forms linked to resistance to older hormone treatments. The study has not started, and there are no patient results yet.